PAN-22, a fully human anit-HAAH monoclonal antibody
|
Indication:
|
Treatment
of hepatocellular carcinoma |
| Stage:
|
Preclinical
|
PAN-622 - Toxin Conjugate
| Indication:
|
Treatment
of carcinoma of the bile duct |
| Stage:
|
Preclinical
|
PAN-811
| Indication:
|
Treatment
of Ischemic Stroke |
| Stage:
|
Preclinical
|
|
